Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
University of Kansas Cancer Center, Westwood, Kansas University of Pennsylvania, Philadelphia, Pennsylvania MD Anderson Cancer Center, Houston, Texas University of Wisconsin Carbone Cancer Center, Madison, Wisconsin